References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Canducci (2011) | Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir. | J Infect Dis | IN HIV1 group M: 38 |